Since the upregulation of PD-L1 can promote tumor proliferation, anti-apoptosis, drug resistance, and invasion, compounds that modulate matrix stiffness or target upstream molecules such as YAP might have potential as drugs for the treatment of lung cancer. This evidence concerns the gene CD274 and lung carcinoma.